Browsing by Subject
Ara mostrant els elements 1-4 d 4
-
Ibrutinib in Combination With Rituximab for Indolent Clinical Forms of Mantle Cell Lymphoma (IMCL-2015): A Multicenter, Open-Label, Single-Arm, Phase II Trial
(American Society of Clinical Oncology, 2022-04-10) -
Real-world evidence of brexucabtagene autoleucel for the treatment of relapsed or refractory mantle cell lymphoma
(American Society of Hematology, 2022-06-28)